Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Picker: An Attenuated CMV Vector |
| Strategy: | Vector vaccines (viral or bacterial) |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays complete |
| Study Start Date: | 2014-09-08 |
| Study Made Public: | 2018-10-03 |
Title
PC301-Gates Therapeutic Vaccine
Description
CAVD 459 (PC301) is a non-human primate study to evaluate therapeutic administration of a CMV/SIV vector-vaccine in Rhesus Macaques with ART-suppressed SIV infection.
Sign in to see full information about this study and to download study data.